High Risk Acetaminophen Ingestion in a Nine-Month-Old Requiring Hemodialysis: A Case Report

Camille Mero1, Raven Haan1, Sandra Al Tamimi2

  • 1Herman and Walter Samuelson Children's Hospital, Pediatric Residency.

Insights

High-risk acetaminophen overdose in infants requires prompt treatment with N-acetylcysteine (NAC) and extracorporeal toxin removal. This case highlights successful multimodal management, including hemodialysis and continuous renal replacement therapy, preventing liver failure.

Area of Science:

  • Pediatric Toxicology
  • Critical Care Medicine
  • Pharmacology

Background:

  • Acetaminophen (APAP) overdose in infants is rare but can lead to rapid metabolic decline and mitochondrial dysfunction.
  • Limited pediatric-specific management guidelines exist for severe APAP poisoning.
  • Early recognition and intervention are critical for survival in infant APAP overdose.

Purpose of the Study:

  • To present a case of successful multimodal management of high-risk acetaminophen poisoning in an infant.
  • To highlight practical considerations for N-acetylcysteine (NAC) dosing during extracorporeal toxin removal.
  • To underscore public health concerns related to medication accessibility and formulation in pediatric ingestions.

Main Methods:

  • A 9-month-old infant ingested a large dose of acetaminophen, presenting with altered mental status, severe metabolic acidosis, coagulopathy, and respiratory failure.
  • Treatment involved high-dose N-acetylcysteine (NAC), fomepizole, intermittent hemodialysis (HD), and continuous renal replacement therapy (CRRT).
  • Management included aggressive phosphorus repletion and prolonged mechanical ventilation.

Main Results:

  • The infant survived without progression to acute liver failure.
  • Extracorporeal toxin removal (HD and CRRT) was a key component of the successful treatment.
  • NAC dose adjustments were necessary during renal replacement therapy.

Conclusions:

  • Multimodal management, including extracorporeal toxin removal and adjunctive therapies, can be effective for severe infant acetaminophen poisoning.
  • Practical challenges in NAC dosing during renal replacement therapy were addressed.
  • Public health strategies, such as limiting acetaminophen quantities and discouraging child-attractive formulations, are needed to prevent severe ingestions.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...